Ambrisentan | 合法藥品大搜索

Ambrisentan(U.S.tradenameLetairis;E.U.tradenameVolibris;IndiatradenamePulmonextbyMSNlabs)isadrugindicatedforuseinthetreatmentof ...

From Wikipedia, the free encyclopedia

Chemical compound

AmbrisentanTrade namesLetairis, Volibris, PulmonextAHFS/Drugs.comMonographMedlinePlusa612023License data PregnancycategoryRoutes ofadministrationBy mouthATC codeLegal status Protein binding99%Elimination half-life15 hours (terminal)

(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid

CAS NumberPubChem CIDIUPHAR/BPSDrugBankChemSpiderUNIIKEGGChEBIChEMBLCompTox Dashboard (EPA)ECHA InfoCard100.184.855 FormulaC22H22N2O4Molar mass378.428 g·mol−13D model (JSmol)

O=C(O)[C@@H](Oc1nc(cc(n1)C)C)C(OC)(c2ccccc2)c3ccccc3

InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1 YKey:OUJTZYPIHDYQMC-LJQANCHMSA-N Y (verify)

Ambrisentan, sold under the brand name Letairis among others, is a drug used for the treatment of pulmonary hypertension.[3][5] It is an endothelin receptor antagon...

高雄榮總肺高壓專業治療中心 | 合法藥品大搜索

臨床使用: 目前Ambrisentan於2009 年12 月1日核准上市。健保核准用在運動能力差(WHO 功能分級III及IV)不明原因 ... Read More

罕見疾病一點通 | 合法藥品大搜索

英文商品名 : Volibris 中文商品名 : 肺博舒主成分 : Ambrisentan 劑型劑量 : 膜衣錠，5 mg/tablet，10 mg/tablet。適應症 : Ambrisentan適用於治療原發性肺動脈高 ... Read More

Ambrisentan | 合法藥品大搜索

Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of ... Read More

Ambrisentan | 合法藥品大搜索

2020年11月20日 — Ambrisentan is an oral medication classified as an endothelin receptor antagonist (ERA) which is approved for the treatment of pulmonary ... Read More

Ambrisentan Mylan | 合法藥品大搜索

Ambrisentan Mylan is a medicine that is used alone or combined with other medicines to treat adults with pulmonary arterial hypertension (PAH). Read More

Ambrisentan Oral: Uses, Side Effects | 合法藥品大搜索

Ambrisentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). This condition is thought to be caused by increased levels of a ... Read More

Ambrisentan: Uses | 合法藥品大搜索

Ambrisentan is an orally active selective type A endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension. It is approved in ... Read More

Ambrisentan | 合法藥品大搜索

Ambrisentan is an orally active selective type A endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension. It is approved in ... Read More

Ambrisentan for the Treatment of Pulmonary Arterial ... | 合法藥品大搜索

由 N Galiè 著作 · 2008 · 被引用 1065 次 — Ambrisentan is a nonsulfonamide, propanoic acid–based, A-selective endothelin receptor antagonist with a bioavailability and half-life that allow once-daily dosing ... Read More

相關資訊整理